OVERVIEW

Prevention and Therapies for Hepatitis and Chronic Liver Disease is organized by University of Louisville (UofL) School of Medicine and will be held on Oct 05, 2024 at Hotel Dena, Pasadena Los Angeles, a Tribute Portfolio Hotel, Pasadena, California, United States of America.

Description:
This seminar series will provide updates on the diagnosis and treatment of the dominant forms of viral hepatitis and explore the latest data on advancing liver PBC, Steatotic Liver Disease and other hepatic conditions. Faculty experts will deliver state-of-the-art material utilizing a curriculum that features lectures, case analysis, current clinical trial outcomes and progress reports on promising prevention approaches and emerging therapies. Available in two formats, the content may be explored as both a live, face-to-face seminar or a web-based, self-paced Enduring Material. It is even possible to combine the two modalities. Either way, the goal of this CME activity is to limit future cases and improve the outcomes of those already infected.

Program Highlights:

The seminar topics are presented in live presentations and supplemented by multi-media pre and post-course assignments. This allows us to make the most of our time together for group discussion, case analysis and patient management approaches.

HCV diagnosis and treatment updates
Epidemiology of Hepatitis B and the best anti-viral therapies
The growing incidence of Delta Hepatitis and its relationship to HBV
Clinical cases to explore End-stage Liver Disease and transplant options
New and emerging therapies showing promise for the treatment of Hepatocellular Carcinoma
Alcohol-associated liver disease
Diagnosing and treating Hepatorenal Syndrome, Hepatic Encephalopathy, and Thrombocytopenia
The explosion in Fatty Liver Disease: A dangerous step on the pathway toward Cirrhosis and HCC
Promising clinical trial data on MASLD and MASH treatment
Caring for liver patients in special populations and circumstances